Granules India Limited (GRANULES)
Outcome of Board Meeting
FY26 results:
Standalone:
Revenue 34.7bn +2% y-y (34.0bn)
EBITDA 7.0bn +6% y-y (6.6bn)
EBITDA margin 20.1% (19.3%) +80 bps y-y
PAT 4.0bn +11% y-y (3.8bn)
Consolidated:
Revenue 53.7bn +7% y-y (50.1bn)
EBITDA 7.6bn +7% y-y (7.1bn)
EBITDA margin 14.1% (14.1%) 0 bps y-y
PAT 5.9bn +14% y-y (5.2bn)
Dividend: None stated
Commentary: The Gagillapur facility received a USFDA Form 483 in October 2026 with no data integrity or cross-contamination observations; company is responding within timelines and expects no impact on manufacturing or distribution.
Source: Original filing PDF
—
view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts
BOT
🚨 GRANULES — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
📎 bseindia.com/xml-data/...
🎧 Audio summary ready
✓✓ 6:47 PM
Instant audio summaries2-min AI concall recap delivered with every earnings alert
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes
Add GRANULES to your watchlist — all of this, automated.
Sign in with Google14-day Pro trial · No credit card · Cancel anytime
More on Granules India Limited
Important.
The summary above is generated automatically from Granules India Limited's own
public regulatory filing under SEBI LODR. Indian Stock Alerts is
not a SEBI-registered Research Analyst or Investment Adviser.
This page is informational, not investment advice, a recommendation to buy
or sell any security, or any opinion about the company's business, governance
or financial health. Always read the original filing before acting and consult
a registered adviser for investment decisions.